Hospital morbidity and mortality of malignant neoplasms of the lip, oral cavity and pharynx in Brazil (2016-2021)
DOI:
https://doi.org/10.46311/2318-0579.61.eUJ4613Keywords:
Hospitalization, indicators of morbidity and mortality, oral neoplasms.Abstract
The aim of this study was to describe the morbidity and hospital mortality of malignant neoplasms of the lip, oral cavity and pharynx in Brazil (from 2016 to 2021). This is an epidemiological, observational, analytical and cross-sectional study of notifications of malignant neoplasms, using information from DATASUS (Brazilian Public Health Service Database) and analyzed using descriptive statistics. A total of 150,025 reports of malignant neoplasms of the lip, oral cavity, and pharynx in Brazil from 2016 to 2021 were analyzed. In 2016, the national rate of malignant neoplasms of the lip, oral cavity, and pharynx was 12.43 per 100,000 inhabitants, decreasing to 10.25 in 2021. Among the regions of the country, the highest rates were found in the South region, ranging from 19.35 in 2016 to 16.40 in 2021. As for the characteristics of hospitalizations, the highest incidence was noted for males (73.76%), the age group was between 50 and 64 years (45.56%), and the race/color was white (43%). Considering the patients hospitalized in the period, 18,185 died, representing a lethality rate of 12.12%. In Brazil, the incidence of oral cancer in the analyzed period differed among the regions. Although the number of hospitalizations for malignant neoplasms of the lip, oral cavity and pharynx remains high, there was a decrease in the period analyzed, with a downward trend in hospitalizations for oral cancer, increasingly emphasizing the need for early action, such as prevention, diagnosis and treatment by dental professionals, as well as public policies to prevent this disease.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Lucimara Cheles da Silva Franzin, Luana Melo de Aragão, Fernanda Ferruzi Lima , Claudio Alberto Franzin , Hermes de Carvalho Hespanhol, Fernanda Mara Franzin
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
I declare/we declare that the text submitted here is original, of my own authorship and does not infringe any type of third party rights. The content is my/our sole responsibility. Possible research involving animals and/or human beings is in accordance with Resolution 196/96 of the National Health Council and its complements. I declare that I am/we are in possession of the written consent of patients and that the research and its procedures were timely and adequately approved by the Ethics Committee of the institution of origin. We further declare that all institutional affiliations and all sources of financial support for the work are duly informed. I certify that there is no commercial or associative interest that represents a conflict of interest related to the submitted work. If there is commercial interest, in addition to the technical and academic ones, in the publication of the article, the information will be reported during the text.